Shanghai Pharmaceuticals Acquires Chinese API Firm

Shanghai Pharmaceuticals (Shanghai, China) says it will acquire a 70% stake in Changzhou Kony Pharm (Changzhou, China), and will also purchase the remaining 30% stake in the next two years. Kony Pharm manufactures active pharmaceutical ingredients (APIs) and pharma intermediates. Financial details of the deal were not disclosed. Kony Pharm is estimated to have sales of about Rmb115 million ($19 million) in 2011, and is expected to maintain high growth in the future, Shanghai Pharmaceuticals says. Kony Pharm focuses on antivirus and cardiovascular therapeutic...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers